Position in GMAB
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$6,479,979
-$3,989,462 QoQ
Shares Held
241,520
-28.9% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 19.5747764160318.ToString("F0")%
Shared 0.ToString("F0")%
None 80.4252235839682.ToString("F0")%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. GMAB ranks #123 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in GMAB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,479,979 | 241,520 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $10,469,441 | 339,917 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $10,062,516 | 328,090 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $11,730,642 | 567,795 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,374,077 | 683,048 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $9,910,285 | 474,858 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $25,707,390 | 1,054,446 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $27,574,418 | 1,097,271 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $32,378,978 | 1,082,547 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $28,310,978 | 889,164 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $32,176,359 | 912,287 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $34,079,611 | 896,596 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $37,573,954 | 995,073 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $38,295,031 | 903,611 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $25,172,277 | 783,451 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $26,368,069 | 811,575 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $30,757,339 | 850,120 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $34,070,692 | 861,241 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $49,278,827 | 1,127,662 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $44,452,679 | 1,088,726 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $28,429,135 | 865,950 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $39,011,803 | 959,464 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $30,787,250 | 840,952 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $22,835,656 | 673,817 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $23,656,936 | 1,116,420 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||